Probenecid - Generic Drug Details
✉ Email this page to a colleague
What are the generic sources for probenecid and what is the scope of freedom to operate?
Probenecid
is the generic ingredient in three branded drugs marketed by Merck, Lannett, Aurobindo Pharma Usa, Ivax Sub Teva Pharms, Lederle, Rising, Watson Labs, and Watson Labs Teva, and is included in eight NDAs. Additional information is available in the individual branded drug profile pages.There are ten drug master file entries for probenecid. Six suppliers are listed for this compound.
Summary for probenecid
| US Patents: | 0 |
| Tradenames: | 3 |
| Applicants: | 8 |
| NDAs: | 8 |
| Drug Master File Entries: | 10 |
| Finished Product Suppliers / Packagers: | 6 |
| Raw Ingredient (Bulk) Api Vendors: | 117 |
| Clinical Trials: | 67 |
| Patent Applications: | 7,981 |
| Formulation / Manufacturing: | see details |
| Drug Prices: | Drug price trends for probenecid |
| What excipients (inactive ingredients) are in probenecid? | probenecid excipients list |
| DailyMed Link: | probenecid at DailyMed |
Recent Clinical Trials for probenecid
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| United States Department of Defense | Phase 3 |
| University of Miami | Phase 3 |
| Haisco Pharmaceutical Group Co., Ltd. | Phase 1 |
Medical Subject Heading (MeSH) Categories for probenecid
US Patents and Regulatory Information for probenecid
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Lederle | PROBENECID | probenecid | TABLET;ORAL | 086917-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| Ivax Sub Teva Pharms | PROBENECID | probenecid | TABLET;ORAL | 083740-001 | May 9, 1984 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| Rising | PROBENECID | probenecid | TABLET;ORAL | 217020-001 | Nov 20, 2023 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
| Watson Labs | PROBENECID | probenecid | TABLET;ORAL | 086150-002 | Apr 23, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| Lannett | PROBALAN | probenecid | TABLET;ORAL | 080966-001 | Approved Prior to Jan 1, 1982 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
| Aurobindo Pharma Usa | PROBENECID | probenecid | TABLET;ORAL | 084211-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
